As of 2025-04-29, the Intrinsic Value of Zimmer Biomet Holdings Inc (ZBH) is 128.69 USD. This ZBH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 101.76 USD, the upside of Zimmer Biomet Holdings Inc is 26.50%.
The range of the Intrinsic Value is 73.74 - 343.71 USD
Based on its market price of 101.76 USD and our intrinsic valuation, Zimmer Biomet Holdings Inc (ZBH) is undervalued by 26.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 73.74 - 343.71 | 128.69 | 26.5% |
| DCF (Growth 10y) | 81.00 - 339.02 | 134.03 | 31.7% |
| DCF (EBITDA 5y) | 92.58 - 184.60 | 132.34 | 30.0% |
| DCF (EBITDA 10y) | 95.41 - 192.63 | 136.01 | 33.7% |
| Fair Value | 114.18 - 114.18 | 114.18 | 12.21% |
| P/E | 165.23 - 218.04 | 197.61 | 94.2% |
| EV/EBITDA | 125.15 - 236.91 | 188.39 | 85.1% |
| EPV | 106.32 - 169.38 | 137.85 | 35.5% |
| DDM - Stable | 42.61 - 186.11 | 114.36 | 12.4% |
| DDM - Multi | 59.67 - 203.82 | 92.45 | -9.1% |
| Market Cap (mil) | 20,132.20 |
| Beta | 0.19 |
| Outstanding shares (mil) | 197.84 |
| Enterprise Value (mil) | 25,811.30 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.86% |
| Cost of Debt | 4.39% |
| WACC | 6.88% |